Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform.
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Interferon beta-1b
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
Dimethylfumarate Impairs Neutrophil Functions.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?

Pages